Phase II Study of Postoperative Concurrent Chemoradiotherapy for Esophageal Squamous Cell Carcinoma (ESO- Shanghai 17)
Clinical trial NCT04764227 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04764227
- Sponsor
- Fudan University
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-05-30
- Primary completion
- 2024-03-30
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.